Free Trial

Catheter Precision Q3 2023 Earnings Report

Catheter Precision logo
$0.46 0.00 (-0.76%)
As of 01/21/2025 04:10 PM Eastern

Catheter Precision EPS Results

Actual EPS
-$2.80
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Catheter Precision Revenue Results

Actual Revenue
$0.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Catheter Precision Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Catheter Precision Earnings Headlines

January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO the market… Unleashing more explosive moves than ever before.
Catheter Ekes up on Order for Product
See More Catheter Precision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email.

About Catheter Precision

Catheter Precision (NYSEAMERICAN:VTAK) designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

View Catheter Precision Profile

More Earnings Resources from MarketBeat